Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    10471456 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Conditions: Chronic Kidney Disease;   Cardiovascular Disease
Interventions: Drug: Spironolactone;   Drug: Placebo
2 Completed Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
Condition: Congestive Heart Failure, Atrial Fibrillation
Intervention: Device: Vitatron biventricular pacemaker
3 Recruiting Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
Condition: ST-elevation Myocardial Infarction
Interventions: Drug: Mineralocorticoid receptor antagonist potassium-canrenoate;   Drug: placebo
4 Unknown  Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy;   Coronary Artery Disease;   Myocardial Diseases
Intervention: Device: Blue Egg Device
5 Completed PIE II: Pharmacological Intervention in the Elderly II
Conditions: Diastolic Heart Failure;   Heart Failure, Congestive
Interventions: Drug: Spironolactone;   Drug: Placebo

Indicates status has not been verified in more than two years